En Es
Categories

Industry News


Siemens Healthineers and Fast-track Diagnostics Form Strategic Relationship

By Labmedica International staff writers
14 Jun 2017

Image: Siemens Healthineers has entered into a new strategic relationship with Fast-track Diagnostics (Photo courtesy of iStock).Siemens Healthineers (Erlangen, Germany), the separately managed healthcare business of Siemens AG, has entered into a new strategic relationship with Fast-track Diagnostics (Sliema, Malta) for the addition of FTD’s broad range of CE-marked kits and multi-syndromic panels to the menu of Siemens Healthineers’ VERSANT kPCR Molecular System. This will allow Siemens Healthineers to provide its customers with expanded, more comprehensive molecular testing solutions.

Siemens Healthineers offers a comprehensive portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. The addition of FTD’s broad menu of kits and panels, which cover conditions from respiratory to gastroenteritis to central nervous system and childhood infections, increases the breadth of Siemens Healthineers’ complete molecular testing solution, ensuring leading-edge performance from extraction through detection and increasing workflow efficiency for molecular labs of all sizes. The VERSANT kPCR Molecular System, an established market player in molecular testing for HIV and Hepatitis, will now feature over 75 assays – consolidating testing for the infectious disease spectrum in a single molecular ecosystem.

“Over the past 24 months, Siemens Healthineers has made significant advancements in the delivery of molecular diagnostic applications and services,” said Fernando Beils, Head of Molecular Diagnostics, Siemens Healthineers. “We continue to strengthen and broaden our Molecular System by offering a comprehensive, scalable solution for accurate diagnosis and monitoring to our customers worldwide through our alliance with Fast-track Diagnostics.”

“The VERSANT kPCR Molecular System is perfectly suited to our wide range of assays, which means laboratories can now diagnose nearly any infectious disease in one workflow,” said Bill Carman, CEO of Fast-track Diagnostics.




E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
Gold member
More info

More articles about Siemens Healthineers

13 Aug 2019
Siemens Healthineers' Acquires Corindus to Enhance Robotic-Assisted Interventions
Siemens Healthineers AG has entered into a merger agreement with Corindus Vascular Robotics, Inc. to acquire the company, which offers a robotic treatment platform for the major vascular therapeutic markets, including coronary, peripheral vascular and neurovascular interventions.
Read More
05 Aug 2019
Siemens Healthineers Receives Recognition AI Applications in Radiology
Based on its recent analysis of the global precision imaging market, Frost & Sullivan, a growth strategy consulting and research firm, has recognized Siemens Healthineers with the 2019 Global Visionary Innovation Leadership Award for leading the effort to establish imaging as an active contributor to precision medicine.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
06 Jun 2018
Siemens Healthineers and ScreenPoint Medical to Develop AI-Based Apps
Siemens Healthineers and ScreenPoint Medical have entered into a partnership to develop artificial intelligence (AI)-based applications for breast imaging. As part of the arrangement, Siemens Healthineers will also acquire a strategic minority stake in ScreenPoint Medical.
Read More
26 Apr 2018
Siemens Healthineers Launches Thermocycler with AI-Powered Software
Siemens Healthineers launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.
Read More
27 Feb 2018
Siemens Healthineers AG IPO Planned for First Half of 2018
Global technology powerhouse Siemens AG and its separately managed healthcare business, Siemens Healthineers have announce that the planned IPO of Siemens Healthineers AG is expected to be completed in the first half of calendar year 2018, subject to capital market conditions.
Read More
18 Jan 2018
Siemens Healthineers Strategy 2025 to Focus on AI
Siemens Healthineers has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.
Read More

Additional news

18 Sep 2019
AI Solution Supporting Wins Best New Radiology Solution Award
An FDA-cleared artificial intelligence (AI) solution that supports breast cancer detection in 3D tomosynthesis has been selected as the winner of “Best New Radiology Solution” Award in the 2019 MedTech Breakthrough Awards program.
Read More
18 Sep 2019
Researchers Develop New AI Technology for Heart Attack Prediction
Researchers from the University of Oxford have developed a technology using artificial intelligence (AI) that could identify people at high risk of a fatal heart attack at least five years before it strikes.
Read More
18 Sep 2019
Quality Processes Fueling Global Refurbished Imaging Equipment Market
The market adoption of refurbished imaging equipment is being fueled by quality refurbishment processes, regulatory relaxations, persuasiveness of a circular economy, and new marketing channels. These are the latest findings of Research and Markets, a global market research company.
Read More
18 Sep 2019
Global POC Testing Market to Reach USD 30 Billion by 2022
The global Point-of-Care (POC) testing market is projected to reach USD 30 billion by 2022, driven by the immense potential of POC tests to improve global health and eventually reduce public and national spending on health.
Read More
18 Sep 2019
Baxter Acquires Cheetah Medical to Expand Specialized Patient Portfolio
Baxter International Inc., a global medical products company, has acquired Cheetah Medical, a provider of non-invasive hemodynamic monitoring technologies.
Read More
12 Sep 2019
ERBA Mannheim Opens New Subsidiary in Brazil
ERBA Mannheim has expanded its global footprint by opening a new subsidiary in Brazil.
Read More
10 Sep 2019
Imaging Informatics Summit Highlights Impact of AI Technologies on Patient Care
The 2019 Imaging Informatics Summit organized by the American College of Radiology will be held in Washington, D.C., USA, on October 5–6, 2019, and will focus on the role that artificial intelligence (AI) and data can play in improving patient care.
Read More
10 Sep 2019
ZOLL Medical Completes Acquisition of Cardiac Science
ZOLL Medical Corporation, which manufactures medical devices and related software solutions, has completed the previously announced acquisition of Cardiac Science Corporation, a provider of automated external defibrillators (AEDs), related services, and accessories.
Read More
10 Sep 2019
Growing Inclination Towards Handheld Ultrasound Scanners for POC Diagnostics
The global handheld ultrasound scanners market was valued at USD 62.2 million in 2017 and is projected to grow at a CAGR of 17% during the forecast period 2018-2026, driven primarily by their increasingly popularity among clinicians across the world for point-of-care diagnosis.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions